Genetic screening for Lynch syndrome as cost-effective as other cancer screening proc

[News]

Myriad Genetics, Inc. today said results from a major health economics study in Cancer Prevention Research, a journal of the American Association for Cancer Research (AACR), found that screening for inherited gene mutations in the genes that cause a major colorectal cancer syndrome called Lynch Syndrome, is both medically and cost effective.

More... (http://www.news-medical.net/news/20101130/Genetic-screening-for-Lynch-syndrome-as-cost-effective-as-other-cancer-screening-procedures.aspx)